Concepedia

Surrogate Endpoint Modeling

Surrogate Endpoint Modeling is a type of cost-effectiveness modeling that uses surrogate endpoints as proxy measures for clinically meaningful outcomes to estimate the long-term effectiveness of health interventions when direct evidence is limited or unavailable.

112

Publications

6.7K

Citations

503

Authors

268

Institutions

Publications per year

2017–2026

28

Parents

Publications

112

ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER

D. Y. Lin, Thomas R. Fleming, Victor De Gruttola · Statistics in Medicine · 1997 · 511 citations

, , +13

Surrogate End Point for Prostate Cancer-Specific Mortality After Radical Prostatectomy or Radiation Therapy

Anthony V. D’Amico, Judd W. Moul, Peter R. Carroll et al. · JNCI Journal of the National Cancer Institute · 2003 · 501 citations

, , +17

Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials

Victor G De Gruttola, Pamela Clax, David L. DeMets et al. · Controlled Clinical Trials · 2001 · 423 citations

, , +11

The intermediate endpoint effect in logistic and probit regression

David P. MacKinnon, Chondra M. Lockwood, C. Hendricks Brown et al. · Clinical Trials · 2007 · 260 citations · Full text

, , +16

Validation of Surrogate end Points in Multiple Randomized Clinical Trials with Failure Time end Points

Tomasz Burzykowski, Geert Molenberghs, Marc Buyse et al. · Journal of the Royal Statistical Society Series C (Applied Statistics) · 2001 · 218 citations · Full text

, , +14

1–5 of 112

Authors

503

  1. MB
    Marc Buyse

    International Drug Development Institute (Belgium), Belgium

    11 publications · 662 citations

    11

    h-index

  2. GM
    Geert Molenberghs

    Hasselt University, Belgium

    11 publications · 533 citations

    10

    h-index

  3. TB
    Tomasz Burzykowski

    Hasselt University, Belgium

    10 publications · 614 citations

    10

    h-index

  4. PB
    Peter B. Gilbert

    Fred Hutch Cancer Center, United States

    8 publications · 524 citations

    8

    h-index

  5. AA
    Ariel Alonso

    Hasselt University, Belgium

    6 publications · 97 citations

    6

    h-index

1–5 of 503

Institutions

268

  1. University of Washington

    Seattle, United States

    14 h-index

    27 publications

    2.2K citations

  2. Fred Hutch Cancer Center

    Seattle, United States

    10 h-index

    34 publications

    3.7K citations

  3. Hasselt University

    Hasselt, Belgium

    10 h-index

    23 publications

    591 citations

  4. National Cancer Institute

    Bethesda, United States

    9 h-index

    15 publications

    943 citations

  5. International Drug Development Institute (Belgium)

    Brussels, Belgium

    9 h-index

    13 publications

    766 citations

  6. Harvard University

    Cambridge, United States

    9 h-index

    21 publications

    1.2K citations

  7. University of Michigan

    Ann Arbor, United States

    7 h-index

    11 publications

    510 citations

  8. Johns Hopkins University

    Baltimore, United States

    6 h-index

    9 publications

    1K citations

1–8 of 268

Venues

  1. Biometrics

    13 publications · 853 citations

    12

    h-index

  2. Statistics in Medicine

    13 publications · 1.1K citations

    12

    h-index

  3. Statistical Methods in Medical Research

    4 publications · 147 citations

    4

    h-index

  4. Biostatistics

    4 publications · 91 citations

    4

    h-index

  5. PubMed

    Repository · 3 publications · 92 citations

    3

    h-index

1–5